CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Down 54.0% in March

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 16,900 shares, a decrease of 54.0% from the February 28th total of 36,700 shares. Based on an average trading volume of 107,500 shares, the days-to-cover ratio is presently 0.2 days.

CERo Therapeutics Stock Down 5.9 %

Shares of CEROW opened at $0.01 on Friday. The business’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01. CERo Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.13.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.